Segment Information (Tables)

3 Months Ended

Mar. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Information

The following tables present the Company's segment information for the 13 weeks ended March 30, 2024 and April 1, 2023 (in $000's):

	Thirteen Weeks Ended
	March 30, 2024		April 1, 2023
Revenues
Biotechnology	$	—	$	—
Discontinued operations	—		3,795
Total Revenues	$	—	$	3,795
Gross profit
Biotechnology	$	—	$	—
Discontinued operations	—		(197)
Total Gross profit	$	—	$	(197)
Operating loss
Biotechnology	$	(1,806)	$	(1,099)
Discontinued operations	—		14,158
Total Operating loss	$	(1,806)	$	13,059
Depreciation and amortization
Biotechnology	$	—	$	364
Discontinued operations	—		96
Total Depreciation and amortization	$	—	$	460
Interest (income) expense, net
Biotechnology	$	252	$	(475)
Discontinued operations	—		181
Total Interest expense, net	$	252	$	(294)
Net income (loss) before income taxes
Biotechnology	$	(2,219)	$	(889)
Discontinued operations	—		13,976
Total Net income before income taxes	$	(2,219)	$	13,087